{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T22:30:28Z","timestamp":1766788228472,"version":"3.40.3"},"publisher-location":"Singapore","reference-count":116,"publisher":"Springer Nature Singapore","isbn-type":[{"type":"print","value":"9789811956416"},{"type":"electronic","value":"9789811956423"}],"license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-981-19-5642-3_6","type":"book-chapter","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:44:40Z","timestamp":1669920280000},"page":"87-101","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genome Editing and Pathological Cardiac Hypertrophy"],"prefix":"10.1007","author":[{"given":"Takao","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"issue":"1","key":"6_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrcardio.2016.139","volume":"14","author":"A Strong","year":"2017","unstructured":"Strong A, Musunuru K (2017) Genome editing in cardiovascular diseases. Nat Rev Cardiol 14(1):11\u201320","journal-title":"Nat Rev Cardiol"},{"issue":"18","key":"6_CR2","doi-asserted-by":"publisher","first-page":"10570","DOI":"10.1073\/pnas.95.18.10570","volume":"95","author":"J Bitinaite","year":"1998","unstructured":"Bitinaite J, Wah DA, Aggarwal AK, Schildkraut I (1998) FokI dimerization is required for DNA cleavage. Proc Natl Acad Sci U S A 95(18):10570\u201310575","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"6_CR3","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","volume":"93","author":"YG Kim","year":"1996","unstructured":"Kim YG, Cha J, Chandrasegaran S (1996) Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A 93(3):1156\u20131160","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"6_CR4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nrg2842","volume":"11","author":"FD Urnov","year":"2010","unstructured":"Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD (2010) Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11(9):636\u2013646","journal-title":"Nat Rev Genet"},{"issue":"6096","key":"6_CR5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816\u2013821","journal-title":"Science"},{"issue":"5959","key":"6_CR6","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.1178811","volume":"326","author":"J Boch","year":"2009","unstructured":"Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A, Bonas U (2009) Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326(5959):1509\u20131512","journal-title":"Science"},{"issue":"6051","key":"6_CR7","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1126\/science.1204094","volume":"333","author":"AJ Bogdanove","year":"2011","unstructured":"Bogdanove AJ, Voytas DF (2011) TAL effectors: customizable proteins for DNA targeting. Science 333(6051):1843\u20131846","journal-title":"Science"},{"issue":"5959","key":"6_CR8","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1126\/science.1178817","volume":"326","author":"MJ Moscou","year":"2009","unstructured":"Moscou MJ, Bogdanove AJ (2009) A simple cipher governs DNA recognition by TAL effectors. Science 326(5959):1501","journal-title":"Science"},{"issue":"2","key":"6_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1534\/genetics.110.120717","volume":"186","author":"M Christian","year":"2010","unstructured":"Christian M, Cermak T, Doyle EL, Schmidt C, Zhang F, Hummel A, Bogdanove AJ, Voytas DF (2010) Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186(2):757\u2013761","journal-title":"Genetics"},{"issue":"6121","key":"6_CR10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F (2013) Multiplex genome engineering using CRISPR\/Cas systems. Science 339(6121):819\u2013823","journal-title":"Science"},{"issue":"6121","key":"6_CR11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM (2013) RNA-guided human genome engineering via Cas9. Science 339(6121):823\u2013826","journal-title":"Science"},{"issue":"3","key":"6_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nbt.2501","volume":"31","author":"WY Hwang","year":"2013","unstructured":"Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JR, Joung JK (2013) Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31(3):227\u2013229","journal-title":"Nat Biotechnol"},{"issue":"3","key":"6_CR13","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nbt.2507","volume":"31","author":"SW Cho","year":"2013","unstructured":"Cho SW, Kim S, Kim JM, Kim JS (2013) Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 31(3):230\u2013232","journal-title":"Nat Biotechnol"},{"issue":"3","key":"6_CR14","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","volume":"163","author":"B Zetsche","year":"2015","unstructured":"Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, van der Oost J, Regev A, Koonin EV, Zhang F (2015) Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163(3):759\u2013771","journal-title":"Cell"},{"issue":"2","key":"6_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.hfc.2017.12.006","volume":"14","author":"JC Ohiri","year":"2018","unstructured":"Ohiri JC, McNally EM (2018) Gene editing and gene-based therapeutics for cardiomyopathies. Heart Fail Clin 14(2):179\u2013188","journal-title":"Heart Fail Clin"},{"issue":"3","key":"6_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/ijms21030733","volume":"21","author":"Q Nguyen","year":"2020","unstructured":"Nguyen Q, Lim KRQ, Yokota T (2020) Genome editing for the understanding and treatment of inherited cardiomyopathies. Int J Mol Sci 21(3):733","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jacbts.2018.11.004","volume":"4","author":"DM German","year":"2019","unstructured":"German DM, Mitalipov S, Mishra A, Kaul S (2019) Therapeutic genome editing in cardiovascular diseases. JACC Basic Transl Sci 4(1):122\u2013131","journal-title":"JACC Basic Transl Sci"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"8960236","DOI":"10.1155\/2017\/8960236","volume":"2017","author":"BM Motta","year":"2017","unstructured":"Motta BM, Pramstaller PP, Hicks AA, Rossini A (2017) The impact of CRISPR\/Cas9 technology on cardiac research: from disease modelling to therapeutic approaches. Stem Cells Int 2017:8960236","journal-title":"Stem Cells Int"},{"issue":"7","key":"6_CR19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1056\/NEJMra1710575","volume":"379","author":"BJ Maron","year":"2018","unstructured":"Maron BJ (2018) Clinical course and management of hypertrophic cardiomyopathy. N Engl J Med 379(7):655\u2013668","journal-title":"N Engl J Med"},{"issue":"14","key":"6_CR20","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113(14):1807\u20131816","journal-title":"Circulation"},{"issue":"17","key":"6_CR21","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMra0902923","volume":"364","author":"H Watkins","year":"2011","unstructured":"Watkins H, Ashrafian H, Redwood C (2011) Inherited cardiomyopathies. N Engl J Med 364(17):1643\u20131656","journal-title":"N Engl J Med"},{"issue":"2","key":"6_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","volume":"29","author":"P Elliott","year":"2008","unstructured":"Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, K\u00fchl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29(2):270\u2013276","journal-title":"Eur Heart J"},{"issue":"23","key":"6_CR23","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200012073432304","volume":"343","author":"M Kamisago","year":"2000","unstructured":"Kamisago M, Sharma SD, DePalma SR, Solomon S, Sharma P, McDonough B, Smoot L, Mullen MP, Woolf PK, Wigle ED, Seidman JG, Seidman CE (2000) Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343(23):1688\u20131696","journal-title":"N Engl J Med"},{"issue":"4","key":"6_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.967026","volume":"5","author":"I Olivotto","year":"2012","unstructured":"Olivotto I, Cecchi F, Poggesi C, Yacoub MH (2012) Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Circ Heart Fail 5(4):535\u2013546","journal-title":"Circ Heart Fail"},{"issue":"7","key":"6_CR25","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","volume":"121","author":"AJ Marian","year":"2017","unstructured":"Marian AJ, Braunwald E (2017) Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res 121(7):749\u2013770","journal-title":"Circ Res"},{"issue":"12","key":"6_CR26","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1253\/circj.CJ-13-0725","volume":"77","author":"M Miura","year":"2013","unstructured":"Miura M, Sakata Y, Miyata S, Nochioka K, Takada T, Tadaki S, Takahashi J, Shiba N, Shimokawa H (2013) Usefulness of combined risk stratification with heart rate and systolic blood pressure in the management of chronic heart failure. A report from the CHART-2 study. Circ J 77(12):2954\u20132962","journal-title":"Circ J"},{"issue":"7","key":"6_CR27","doi-asserted-by":"publisher","first-page":"H813","DOI":"10.1152\/ajpheart.00602.2015","volume":"310","author":"Y Nakada","year":"2016","unstructured":"Nakada Y, Kawakami R, Nakano T, Takitsume A, Nakagawa H, Ueda T, Nishida T, Onoue K, Soeda T, Okayama S, Takeda Y, Watanabe M, Kawata H, Okura H, Saito Y (2016) Sex differences in clinical characteristics and long-term outcome in acute decompensated heart failure patients with preserved and reduced ejection fraction. Am J Physiol Heart Circ Physiol 310(7):H813\u2013H820","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"25","key":"6_CR28","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","volume":"67","author":"AG Japp","year":"2016","unstructured":"Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK (2016) The diagnosis and evaluation of dilated cardiomyopathy. J Am Coll Cardiol 67(25):2996\u20133010","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"6_CR29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa1110186","volume":"366","author":"DS Herman","year":"2012","unstructured":"Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, Conner L, DePalma SR, McDonough B, Sparks E, Teodorescu DL, Cirino AL, Banner NR, Pennell DJ, Graw S, Merlo M, Di Lenarda A, Sinagra G, Bos JM, Ackerman MJ, Mitchell RN, Murry CE, Lakdawala NK, Ho CY, Barton PJ, Cook SA, Mestroni L, Seidman JG, Seidman CE (2012) Truncations of titin causing dilated cardiomyopathy. N Engl J Med 366(7):619\u2013628","journal-title":"N Engl J Med"},{"issue":"16","key":"6_CR30","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.jacc.2011.01.015","volume":"57","author":"RE Hershberger","year":"2011","unstructured":"Hershberger RE, Siegfried JD (2011) Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 57(16):1641\u20131649","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"6_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/CIRCRESAHA.107.148379","volume":"101","author":"S Rajan","year":"2007","unstructured":"Rajan S, Ahmed RP, Jagatheesan G, Petrashevskaya N, Boivin GP, Urboniene D, Arteaga GM, Wolska BM, Solaro RJ, Liggett SB, Wieczorek DF (2007) Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity. Circ Res 101(2):205\u2013214","journal-title":"Circ Res"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev.med.052208.130419","volume":"61","author":"S Sen-Chowdhry","year":"2010","unstructured":"Sen-Chowdhry S, Morgan RD, Chambers JC, McKenna WJ (2010) Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. Annu Rev Med 61:233\u2013253","journal-title":"Annu Rev Med"},{"issue":"10","key":"6_CR33","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1253\/circj.CJ-14-0893","volume":"78","author":"JA Towbin","year":"2014","unstructured":"Towbin JA (2014) Inherited cardiomyopathies. Circ J 78(10):2347\u20132356","journal-title":"Circ J"},{"issue":"7","key":"6_CR34","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1172\/JCI27751","volume":"116","author":"E Garcia-Gras","year":"2006","unstructured":"Garcia-Gras E, Lombardi R, Giocondo MJ, Willerson JT, Schneider MD, Khoury DS, Marian AJ (2006) Suppression of canonical Wnt\/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Investig 116(7):2012\u20132021","journal-title":"J Clin Investig"},{"issue":"9","key":"6_CR35","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1161\/CIRCRESAHA.109.196899","volume":"104","author":"R Lombardi","year":"2009","unstructured":"Lombardi R, Dong J, Rodriguez G, Bell A, Leung TK, Schwartz RJ, Willerson JT, Brugada R, Marian AJ (2009) Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res 104(9):1076\u20131084","journal-title":"Circ Res"},{"issue":"1","key":"6_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/cvr\/cvp183","volume":"84","author":"F Djouadi","year":"2009","unstructured":"Djouadi F, Lecarpentier Y, H\u00e9bert JL, Charron P, Bastin J, Coirault C (2009) A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Res 84(1):83\u201390","journal-title":"Cardiovasc Res"},{"issue":"4","key":"6_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.hfc.2010.06.005","volume":"6","author":"JA Towbin","year":"2010","unstructured":"Towbin JA (2010) Left ventricular noncompaction: a new form of heart failure. Heart Fail Clin 6(4):453\u2013469, viii","journal-title":"Heart Fail Clin"},{"issue":"2","key":"6_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.hfc.2009.11.005","volume":"6","author":"S Sen-Chowdhry","year":"2010","unstructured":"Sen-Chowdhry S, Syrris P, McKenna WJ (2010) Genetics of restrictive cardiomyopathy. Heart Fail Clin 6(2):179\u2013186","journal-title":"Heart Fail Clin"},{"issue":"9","key":"6_CR39","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/ajmg.a.34097","volume":"155A","author":"C Caleshu","year":"2011","unstructured":"Caleshu C, Sakhuja R, Nussbaum RL, Schiller NB, Ursell PC, Eng C, De Marco T, McGlothlin D, Burchard EG, Rame JE (2011) Furthering the link between the sarcomere and primary cardiomyopathies: restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy. Am J Med Genet A 155A(9):2229\u20132235","journal-title":"Am J Med Genet A"},{"issue":"10","key":"6_CR40","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1161\/CIRCRESAHA.116.309948","volume":"120","author":"I Karakikes","year":"2017","unstructured":"Karakikes I, Termglinchan V, Cepeda DA, Lee J, Diecke S, Hendel A, Itzhaki I, Ameen M, Shrestha R, Wu H, Ma N, Shao NY, Seeger T, Woo N, Wilson KD, Matsa E, Porteus MH, Sebastiano V, Wu JC (2017) A comprehensive TALEN-based knockout library for generating human-induced pluripotent stem cell-based models for cardiovascular diseases. Circ Res 120(10):1561\u20131571","journal-title":"Circ Res"},{"issue":"15","key":"6_CR41","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1161\/CIRCULATIONAHA.109.868885","volume":"120","author":"L Zwi","year":"2009","unstructured":"Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park IH, Gepstein L (2009) Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120(15):1513\u20131523","journal-title":"Circulation"},{"issue":"9","key":"6_CR42","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1002\/stem.2070","volume":"33","author":"C Yang","year":"2015","unstructured":"Yang C, Al-Aama J, Stojkovic M, Keavney B, Trafford A, Lako M, Armstrong L (2015) Concise review: cardiac disease modeling using induced pluripotent stem cells. Stem Cells 33(9):2643\u20132651","journal-title":"Stem Cells"},{"issue":"5","key":"6_CR43","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s12015-015-9600-1","volume":"11","author":"B Grobarczyk","year":"2015","unstructured":"Grobarczyk B, Franco B, Hanon K, Malgrange B (2015) Generation of isogenic human iPS cell line precisely corrected by genome editing using the CRISPR\/Cas9 system. Stem Cell Rev Rep 11(5):774\u2013787","journal-title":"Stem Cell Rev Rep"},{"issue":"50","key":"6_CR44","doi-asserted-by":"publisher","first-page":"E5383","DOI":"10.1073\/pnas.1419553111","volume":"111","author":"M Zhang","year":"2014","unstructured":"Zhang M, D\u2019Aniello C, Verkerk AO, Wrobel E, Frank S, Ward-van Oostwaard D, Piccini I, Freund C, Rao J, Seebohm G, Atsma DE, Schulze-Bahr E, Mummery CL, Greber B, Bellin M (2014) Recessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue. Proc Natl Acad Sci U S A 111(50):E5383\u2013E5392","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"6_CR45","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.celrep.2015.04.007","volume":"11","author":"FT Merkle","year":"2015","unstructured":"Merkle FT, Neuhausser WM, Santos D, Valen E, Gagnon JA, Maas K, Sandoe J, Schier AF, Eggan K (2015) Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus. Cell Rep 11(6):875\u2013883. https:\/\/doi.org\/10.1016\/j.celrep.2015.04.007","journal-title":"Cell Rep"},{"issue":"6251","key":"6_CR46","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1126\/science.aaa5458","volume":"349","author":"JT Hinson","year":"2015","unstructured":"Hinson JT, Chopra A, Nafissi N, Polacheck WJ, Benson CC, Swist S, Gorham J, Yang L, Schafer S, Sheng CC, Haghighi A, Homsy J, Hubner N, Church G, Cook SA, Linke WA, Chen CS, Seidman JG, Seidman CE (2015) HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science 349(6251):982\u2013986","journal-title":"Science"},{"issue":"3","key":"6_CR47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCULATIONAHA.118.037227","volume":"140","author":"F Jaffr\u00e9","year":"2019","unstructured":"Jaffr\u00e9 F, Miller CL, Sch\u00e4nzer A, Evans T, Roberts AE, Hahn A, Kontaridis MI (2019) Inducible pluripotent stem cell-derived cardiomyocytes reveal aberrant extracellular regulated kinase 5 and mitogen-activated protein kinase kinase 1\/2 signaling concomitantly promote hypertrophic cardiomyopathy in RAF1-associated Noonan syndrome. Circulation 140(3):207\u2013224","journal-title":"Circulation"},{"issue":"6","key":"6_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1161\/CIRCULATIONAHA.118.034624","volume":"139","author":"T Seeger","year":"2019","unstructured":"Seeger T, Shrestha R, Lam CK, Chen C, McKeithan WL, Lau E, Wnorowski A, McMullen G, Greenhaw M, Lee J, Oikonomopoulos A, Lee S, Yang H, Mercola M, Wheeler M, Ashley EA, Yang F, Karakikes I, Wu JC (2019) A premature termination codon mutation in MYBPC3 causes hypertrophic cardiomyopathy via chronic activation of nonsense-mediated decay. Circulation 139(6):799\u2013811","journal-title":"Circulation"},{"issue":"23","key":"6_CR49","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1161\/CIRCULATIONAHA.117.032273","volume":"138","author":"N Ma","year":"2018","unstructured":"Ma N, Zhang JZ, Itzhaki I, Zhang SL, Chen H, Haddad F, Kitani T, Wilson KD, Tian L, Shrestha R, Wu H, Lam CK, Sayed N, Wu JC (2018) Determining the pathogenicity of a genomic variant of uncertain significance using CRISPR\/Cas9 and human-induced pluripotent stem cells. Circulation 138(23):2666\u20132681","journal-title":"Circulation"},{"issue":"4","key":"6_CR50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/jpm8040038","volume":"8","author":"KRQ Lim","year":"2018","unstructured":"Lim KRQ, Yoon C, Yokota T (2018) Applications of CRISPR\/Cas9 for the treatment of Duchenne muscular dystrophy. J Pers Med 8(4):38","journal-title":"J Pers Med"},{"key":"6_CR51","doi-asserted-by":"publisher","first-page":"175628641983347","DOI":"10.1177\/1756286419833478","volume":"12","author":"D Piga","year":"2019","unstructured":"Piga D, Salani S, Magri F, Brusa R, Mauri E, Comi GP, Bresolin N, Corti S (2019) Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies. Ther Adv Neurol Disord 12:1756286419833478","journal-title":"Ther Adv Neurol Disord"},{"issue":"3","key":"6_CR52","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s12195-015-0413-8","volume":"8","author":"J Macadangdang","year":"2015","unstructured":"Macadangdang J, Guan X, Smith AS, Lucero R, Czerniecki S, Childers MK, Mack DL, Kim DH (2015) Nanopatterned human iPSC-based model of a dystrophin-null cardiomyopathic phenotype. Cell Mol Bioeng 8(3):320\u2013332. https:\/\/doi.org\/10.1007\/s12195-015-0413-8","journal-title":"Cell Mol Bioeng"},{"issue":"3","key":"6_CR53","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pharmthera.2013.10.007","volume":"141","author":"N Milani-Nejad","year":"2014","unstructured":"Milani-Nejad N, Janssen PM (2014) Small and large animal models in cardiac contraction research: advantages and disadvantages. Pharmacol Ther 141(3):235\u2013249","journal-title":"Pharmacol Ther"},{"key":"6_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/497841","volume":"2011","author":"C Zaragoza","year":"2011","unstructured":"Zaragoza C, Gomez-Guerrero C, Martin-Ventura JL, Blanco-Colio L, Lavin B, Mallavia B, Tarin C, Mas S, Ortiz A, Egido J (2011) Animal models of cardiovascular diseases. J Biomed Biotechnol 2011:497841","journal-title":"J Biomed Biotechnol"},{"issue":"Unit 19.12","key":"6_CR55","first-page":"19.12.11-17","volume":"Chapter 19","author":"B Hall","year":"2009","unstructured":"Hall B, Limaye A, Kulkarni AB (2009) Overview: generation of gene knockout mice. Curr Protoc Cell Biol Chapter 19(Unit 19.12):19.12.11-17","journal-title":"Curr Protoc Cell Biol"},{"issue":"6","key":"6_CR56","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.cell.2013.08.022","volume":"154","author":"H Yang","year":"2013","unstructured":"Yang H, Wang H, Shivalila CS, Cheng AW, Shi L, Jaenisch R (2013) One-step generation of mice carrying reporter and conditional alleles by CRISPR\/Cas-mediated genome engineering. Cell 154(6):1370\u20131379","journal-title":"Cell"},{"issue":"12","key":"6_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168486","volume":"11","author":"M Kaneko","year":"2016","unstructured":"Kaneko M, Hashikami K, Yamamoto S, Matsumoto H, Nishimoto T (2016) Phospholamban ablation using CRISPR\/Cas9 system improves mortality in a murine heart failure model. PLoS One 11(12):e0168486","journal-title":"PLoS One"},{"issue":"6201","key":"6_CR58","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1126\/science.1254445","volume":"345","author":"C Long","year":"2014","unstructured":"Long C, McAnally JR, Shelton JM, Mireault AA, Bassel-Duby R, Olson EN (2014) Prevention of muscular dystrophy in mice by CRISPR\/Cas9-mediated editing of germline DNA. Science 345(6201):1184\u20131188","journal-title":"Science"},{"issue":"7668","key":"6_CR59","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature23305","volume":"548","author":"H Ma","year":"2017","unstructured":"Ma H, Marti-Gutierrez N, Park SW, Wu J, Lee Y, Suzuki K, Koski A, Ji D, Hayama T, Ahmed R, Darby H, Van Dyken C, Li Y, Kang E, Park AR, Kim D, Kim ST, Gong J, Gu Y, Xu X, Battaglia D, Krieg SA, Lee DM, Wu DH, Wolf DP, Heitner SB, Belmonte JCI, Amato P, Kim JS, Kaul S, Mitalipov S (2017) Correction of a pathogenic gene mutation in human embryos. Nature 548(7668):413\u2013419","journal-title":"Nature"},{"issue":"9","key":"6_CR60","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31(9):822\u2013826","journal-title":"Nat Biotechnol"},{"issue":"4","key":"6_CR61","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.yjmcc.2011.01.014","volume":"50","author":"S Schlossarek","year":"2011","unstructured":"Schlossarek S, Mearini G, Carrier L (2011) Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities. J Mol Cell Cardiol 50(4):613\u2013620","journal-title":"J Mol Cell Cardiol"},{"key":"6_CR62","doi-asserted-by":"publisher","first-page":"5515","DOI":"10.1038\/ncomms6515","volume":"5","author":"G Mearini","year":"2014","unstructured":"Mearini G, Stimpel D, Geertz B, Weinberger F, Kr\u00e4mer E, Schlossarek S, Mourot-Filiatre J, Stoehr A, Dutsch A, Wijnker PJ, Braren I, Katus HA, M\u00fcller OJ, Voit T, Eschenhagen T, Carrier L (2014) Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice. Nat Commun 5:5515","journal-title":"Nat Commun"},{"key":"6_CR63","doi-asserted-by":"publisher","first-page":"1652567","DOI":"10.1155\/2018\/1652567","volume":"2018","author":"LF Ribeiro","year":"2018","unstructured":"Ribeiro LF, Ribeiro LFC, Barreto MQ, Ward RJ (2018) Protein engineering strategies to expand CRISPR-Cas9 applications. Int J Genomics 2018:1652567","journal-title":"Int J Genomics"},{"issue":"6410","key":"6_CR64","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.aau1549","volume":"362","author":"L Amoasii","year":"2018","unstructured":"Amoasii L, Hildyard JCW, Li H, Sanchez-Ortiz E, Mireault A, Caballero D, Harron R, Stathopoulou TR, Massey C, Shelton JM, Bassel-Duby R, Piercy RJ, Olson EN (2018) Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy. Science 362(6410):86\u201391","journal-title":"Science"},{"issue":"2","key":"6_CR65","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41591-019-0738-2","volume":"26","author":"A Moretti","year":"2020","unstructured":"Moretti A, Fonteyne L, Giesert F, Hoppmann P, Meier AB, Bozoglu T, Baehr A, Schneider CM, Sinnecker D, Klett K, Fr\u00f6hlich T, Rahman FA, Haufe T, Sun S, Jurisch V, Kessler B, Hinkel R, Dirschinger R, Martens E, Jilek C, Graf A, Krebs S, Santamaria G, Kurome M, Zakhartchenko V, Campbell B, Voelse K, Wolf A, Ziegler T, Reichert S, Lee S, Flenkenthaler F, Dorn T, Jeremias I, Blum H, Dendorfer A, Schnieke A, Krause S, Walter MC, Klymiuk N, Laugwitz KL, Wolf E, Wurst W, Kupatt C (2020) Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy. Nat Med 26(2):207\u2013214","journal-title":"Nat Med"},{"issue":"4","key":"6_CR66","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/mus.21716","volume":"42","author":"C Van Erp","year":"2010","unstructured":"Van Erp C, Loch D, Laws N, Trebbin A, Hoey AJ (2010) Timeline of cardiac dystrophy in 3-18-month-old MDX mice. Muscle Nerve 42(4):504\u2013513","journal-title":"Muscle Nerve"},{"issue":"23","key":"6_CR67","doi-asserted-by":"publisher","first-page":"e124297","DOI":"10.1172\/jci.insight.124297","volume":"3","author":"CH Hakim","year":"2018","unstructured":"Hakim CH, Wasala NB, Nelson CE, Wasala LP, Yue Y, Louderman JA, Lessa TB, Dai A, Zhang K, Jenkins GJ, Nance ME, Pan X, Kodippili K, Yang NN, Chen SJ, Gersbach CA, Duan D (2018) AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice. JCI Insight 3(23):e124297","journal-title":"JCI Insight"},{"issue":"8","key":"6_CR68","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.ymthe.2019.05.001","volume":"27","author":"L Xu","year":"2019","unstructured":"Xu L, Lau YS, Gao Y, Li H, Han R (2019) Life-Long AAV-mediated CRISPR genome editing in dystrophic heart improves cardiomyopathy without causing serious lesions in mdx mice. Mol Ther 27(8):1407\u20131414","journal-title":"Mol Ther"},{"issue":"3","key":"6_CR69","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","volume":"25","author":"CE Nelson","year":"2019","unstructured":"Nelson CE, Wu Y, Gemberling MP, Oliver ML, Waller MA, Bohning JD, Robinson-Hamm JN, Bulaklak K, Castellanos Rivera RM, Collier JH, Asokan A, Gersbach CA (2019) Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nat Med 25(3):427\u2013432","journal-title":"Nat Med"},{"issue":"9","key":"6_CR70","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41434-021-00222-4","volume":"28","author":"C Kupatt","year":"2021","unstructured":"Kupatt C, Windisch A, Moretti A, Wolf E, Wurst W, Walter MC (2021) Genome editing for Duchenne muscular dystrophy: a glimpse of the future? Gene Ther 28(9):542\u2013548. https:\/\/doi.org\/10.1038\/s41434-021-00222-4","journal-title":"Gene Ther"},{"issue":"9","key":"6_CR71","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","volume":"22","author":"JD Finn","year":"2018","unstructured":"Finn JD, Smith AR, Patel MC, Shaw L, Youniss MR, van Heteren J, Dirstine T, Ciullo C, Lescarbeau R, Seitzer J, Shah RR, Shah A, Ling D, Growe J, Pink M, Rohde E, Wood KM, Salomon WE, Harrington WF, Dombrowski C, Strapps WR, Chang Y, Morrissey DV (2018) A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing. Cell Rep 22(9):2227\u20132235","journal-title":"Cell Rep"},{"issue":"12","key":"6_CR72","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/S0301-5629(03)00976-1","volume":"29","author":"JP Christiansen","year":"2003","unstructured":"Christiansen JP, French BA, Klibanov AL, Kaul S, Lindner JR (2003) Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol 29(12):1759\u20131767","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"6_CR73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/CIRCRESAHA.116.309283","volume":"120","author":"WB Limpitikul","year":"2017","unstructured":"Limpitikul WB, Dick IE, Tester DJ, Boczek NJ, Limphong P, Yang W, Choi MH, Babich J, DiSilvestre D, Kanter RJ, Tomaselli GF, Ackerman MJ, Yue DT (2017) A precision medicine approach to the rescue of function on malignant calmodulinopathic long-QT syndrome. Circ Res 120(1):39\u201348","journal-title":"Circ Res"},{"issue":"4","key":"6_CR74","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.molcel.2012.07.029","volume":"47","author":"JR Chapman","year":"2012","unstructured":"Chapman JR, Taylor MR, Boulton SJ (2012) Playing the end game: DNA double-strand break repair pathway choice. Mol Cell 47(4):497\u2013510","journal-title":"Mol Cell"},{"issue":"5","key":"6_CR75","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nbt.3190","volume":"33","author":"T Maruyama","year":"2015","unstructured":"Maruyama T, Dougan SK, Truttmann MC, Bilate AM, Ingram JR, Ploegh HL (2015) Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol 33(5):538\u2013542","journal-title":"Nat Biotechnol"},{"issue":"5","key":"6_CR76","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nbt.3198","volume":"33","author":"VT Chu","year":"2015","unstructured":"Chu VT, Weber T, Wefers B, Wurst W, Sander S, Rajewsky K, K\u00fchn R (2015) Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol 33(5):543\u2013548","journal-title":"Nat Biotechnol"},{"key":"6_CR77","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.04766","volume":"3","author":"S Lin","year":"2014","unstructured":"Lin S, Staahl BT, Alla RK, Doudna JA (2014) Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery. Elife 3:e04766","journal-title":"Elife"},{"issue":"3","key":"6_CR78","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.stemcr.2016.07.001","volume":"7","author":"SE Howden","year":"2016","unstructured":"Howden SE, McColl B, Glaser A, Vadolas J, Petrou S, Little MH, Elefanty AG, Stanley EG (2016) A Cas9 variant for efficient generation of indel-free knockin or gene-corrected human pluripotent stem cells. Stem Cell Reports 7(3):508\u2013517","journal-title":"Stem Cell Reports"},{"issue":"7631","key":"6_CR79","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nature20565","volume":"540","author":"K Suzuki","year":"2016","unstructured":"Suzuki K, Tsunekawa Y, Hernandez-Benitez R, Wu J, Zhu J, Kim EJ, Hatanaka F, Yamamoto M, Araoka T, Li Z, Kurita M, Hishida T, Li M, Aizawa E, Guo S, Chen S, Goebl A, Soligalla RD, Qu J, Jiang T, Fu X, Jafari M, Esteban CR, Berggren WT, Lajara J, Nu\u00f1ez-Delicado E, Guillen P, Campistol JM, Matsuzaki F, Liu GH, Magistretti P, Zhang K, Callaway EM, Zhang K, Belmonte JC (2016) In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration. Nature 540(7631):144\u2013149","journal-title":"Nature"},{"issue":"6","key":"6_CR80","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","volume":"154","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, Zhang F (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154(6):1380\u20131389","journal-title":"Cell"},{"issue":"4","key":"6_CR81","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nmeth.2857","volume":"11","author":"B Shen","year":"2014","unstructured":"Shen B, Zhang W, Zhang J, Zhou J, Wang J, Chen L, Wang L, Hodgkins A, Iyer V, Huang X, Skarnes WC (2014) Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nat Methods 11(4):399\u2013402","journal-title":"Nat Methods"},{"issue":"12","key":"6_CR82","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky222","volume":"46","author":"R Gopalappa","year":"2018","unstructured":"Gopalappa R, Suresh B, Ramakrishna S, Kim HH (2018) Paired D10A Cas9 nickases are sometimes more efficient than individual nucleases for gene disruption. Nucleic Acids Res 46(12):e71","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"6_CR83","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/mt.2016.172","volume":"24","author":"Y Chen","year":"2016","unstructured":"Chen Y, Liu X, Zhang Y, Wang H, Ying H, Liu M, Li D, Lui KO, Ding Q (2016) A self-restricted CRISPR system to reduce off-target effects. Mol Ther 24(9):1508\u20131510. https:\/\/doi.org\/10.1038\/mt.2016.172","journal-title":"Mol Ther"},{"issue":"3","key":"6_CR84","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1165","volume":"47","author":"CC Shen","year":"2019","unstructured":"Shen CC, Hsu MN, Chang CW, Lin MW, Hwu JR, Tu Y, Hu YC (2019) Synthetic switch to minimize CRISPR off-target effects by self-restricting Cas9 transcription and translation. Nucleic Acids Res 47(3):e13","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"6_CR85","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/nar\/gku1326","volume":"43","author":"R Moore","year":"2015","unstructured":"Moore R, Spinhirne A, Lai MJ, Preisser S, Li Y, Kang T, Bleris L (2015) CRISPR-based self-cleaving mechanism for controllable gene delivery in human cells. Nucleic Acids Res 43(2):1297\u20131303","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"6_CR86","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2016.07.004","volume":"63","author":"J Tycko","year":"2016","unstructured":"Tycko J, Myer VE, Hsu PD (2016) Methods for optimizing CRISPR-Cas9 genome editing specificity. Mol Cell 63(3):355\u2013370. https:\/\/doi.org\/10.1016\/j.molcel.2016.07.004","journal-title":"Mol Cell"},{"issue":"9","key":"6_CR87","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nbt.2673","volume":"31","author":"V Pattanayak","year":"2013","unstructured":"Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR (2013) High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol 31(9):839\u2013843","journal-title":"Nat Biotechnol"},{"issue":"3","key":"6_CR88","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nbt.2808","volume":"32","author":"Y Fu","year":"2014","unstructured":"Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK (2014) Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol 32(3):279\u2013284","journal-title":"Nat Biotechnol"},{"key":"6_CR89","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biochi.2019.09.003","volume":"167","author":"J Filippova","year":"2019","unstructured":"Filippova J, Matveeva A, Zhuravlev E, Stepanov G (2019) Guide RNA modification as a way to improve CRISPR\/Cas9-based genome-editing systems. Biochimie 167:49\u201360","journal-title":"Biochimie"},{"issue":"1","key":"6_CR90","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1038\/s41467-019-12281-8","volume":"10","author":"D Wang","year":"2019","unstructured":"Wang D, Zhang C, Wang B, Li B, Wang Q, Liu D, Wang H, Zhou Y, Shi L, Lan F, Wang Y (2019) Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning. Nat Commun 10(1):4284","journal-title":"Nat Commun"},{"issue":"2","key":"6_CR91","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, Wyvekens N, Khayter C, Iafrate AJ, Le LP, Aryee MJ, Joung JK (2015) GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol 33(2):187\u2013197","journal-title":"Nat Biotechnol"},{"issue":"3","key":"6_CR92","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nmeth.3284","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Bae S, Park J, Kim E, Kim S, Yu HR, Hwang J, Kim JI, Kim JS (2015) Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat Methods 12(3):237\u2013243, 1 p following 243","journal-title":"Nat Methods"},{"issue":"3","key":"6_CR93","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ymthe.2019.01.015","volume":"27","author":"CM Guenther","year":"2019","unstructured":"Guenther CM, Brun MJ, Bennett AD, Ho ML, Chen W, Zhu B, Lam M, Yamagami M, Kwon S, Bhattacharya N, Sousa D, Evans AC, Voss J, Sevick-Muraca EM, Agbandje-McKenna M, Suh J (2019) Protease-Activatable adeno-associated virus vector for gene delivery to damaged heart tissue. Mol Ther 27(3):611\u2013622","journal-title":"Mol Ther"},{"issue":"2","key":"6_CR94","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/genes8020065","volume":"8","author":"CL Hardee","year":"2017","unstructured":"Hardee CL, Ar\u00e9valo-Soliz LM, Hornstein BD, Zechiedrich L (2017) Advances in non-viral DNA vectors for gene therapy. Genes (Basel) 8(2):65","journal-title":"Genes (Basel)"},{"issue":"11","key":"6_CR95","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41578-019-0145-9","volume":"4","author":"S Tong","year":"2019","unstructured":"Tong S, Moyo B, Lee CM, Leong K, Bao G (2019) Engineered materials for in vivo delivery of genome-editing machinery. Nat Rev Mater 4(11):726\u2013737","journal-title":"Nat Rev Mater"},{"issue":"6","key":"6_CR96","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1021\/acs.accounts.9b00106","volume":"52","author":"D Wilbie","year":"2019","unstructured":"Wilbie D, Walther J, Mastrobattista E (2019) Delivery aspects of CRISPR\/Cas for in vivo genome editing. Acc Chem Res 52(6):1555\u20131564","journal-title":"Acc Chem Res"},{"key":"6_CR97","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","volume":"1","author":"K Lee","year":"2017","unstructured":"Lee K, Conboy M, Park HM, Jiang F, Kim HJ, Dewitt MA, Mackley VA, Chang K, Rao A, Skinner C, Shobha T, Mehdipour M, Liu H, Huang WC, Lan F, Bray NL, Li S, Corn JE, Kataoka K, Doudna JA, Conboy I, Murthy N (2017) Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair. Nat Biom Eng 1:889\u2013901","journal-title":"Nat Biom Eng"},{"issue":"5262","key":"6_CR98","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1126\/science.272.5262.731","volume":"272","author":"AAT Geisterfer-Lowrance","year":"1996","unstructured":"Geisterfer-Lowrance AAT, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG (1996) A mouse model of familial hypertrophic cardiomyopathy. Science 272(5262):731\u2013734","journal-title":"Science"},{"key":"6_CR99","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.yjmcc.2017.01.006","volume":"103","author":"R Hueneke","year":"2017","unstructured":"Hueneke R, Adenwala A, Mellor RL, Seidman JG, Seidman CE, Nerbonne JM (2017) Early remodeling of repolarizing K(+) currents in the \u03b1MHC(403\/+) mouse model of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 103:93\u2013101","journal-title":"J Mol Cell Cardiol"},{"key":"6_CR100","doi-asserted-by":"crossref","unstructured":"Rehmani T, Salih M, Tuana BS (2019) Cardiac-specific Cre induces age-dependent dilated cardiomyopathy (DCM) in mice. Molecules 24(6):\u20131189","DOI":"10.3390\/molecules24061189"},{"issue":"41","key":"6_CR101","doi-asserted-by":"publisher","first-page":"38988","DOI":"10.1074\/jbc.M205511200","volume":"277","author":"SE Woodman","year":"2002","unstructured":"Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J, Tang B, Jelicks LA, Kitsis RN, Christ GJ, Factor SM, Tanowitz HB, Lisanti MP (2002) Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42\/44 MAPK cascade. J Biol Chem 277(41):38988\u201338997","journal-title":"J Biol Chem"},{"issue":"15","key":"6_CR102","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1093\/hmg\/ddr201","volume":"20","author":"A Kuga","year":"2011","unstructured":"Kuga A, Ohsawa Y, Okada T, Kanda F, Kanagawa M, Toda T, Sunada Y (2011) Endoplasmic reticulum stress response in P104L mutant caveolin-3 transgenic mice. Hum Mol Genet 20(15):2975\u20132983","journal-title":"Hum Mol Genet"},{"issue":"10","key":"6_CR103","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1006\/jmcc.2001.1445","volume":"33","author":"R Prabhakar","year":"2001","unstructured":"Prabhakar R, Boivin GP, Grupp IL, Hoit B, Arteaga G, Solaro RJ, Wieczorek DF (2001) A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. J Mol Cell Cardiol 33(10):1815\u20131828","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"6_CR104","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/01.RES.85.1.47","volume":"85","author":"M Muthuchamy","year":"1999","unstructured":"Muthuchamy M, Pieples K, Rethinasamy P, Hoit B, Grupp IL, Boivin GP, Wolska B, Evans C, Solaro RJ, Wieczorek DF (1999) Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction. Circ Res 85(1):47\u201356","journal-title":"Circ Res"},{"issue":"12","key":"6_CR105","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1172\/JCI2389","volume":"101","author":"JC Tardiff","year":"1998","unstructured":"Tardiff JC, Factor SM, Tompkins BD, Hewett TE, Palmer BM, Moore RL, Schwartz S, Robbins J, Leinwand LA (1998) A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. J Clin Investig 101(12):2800\u20132811","journal-title":"J Clin Investig"},{"issue":"4","key":"6_CR106","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1172\/JCI6067","volume":"104","author":"JC Tardiff","year":"1999","unstructured":"Tardiff JC, Hewett TE, Palmer BM, Olsson C, Factor SM, Moore RL, Robbins J, Leinwand LA (1999) Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Investig 104(4):469\u2013481","journal-title":"J Clin Investig"},{"issue":"9","key":"6_CR107","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/01.RES.87.9.805","volume":"87","author":"J James","year":"2000","unstructured":"James J, Zhang Y, Osinska H, Sanbe A, Klevitsky R, Hewett TE, Robbins J (2000) Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy. Circ Res 87(9):805\u2013811","journal-title":"Circ Res"},{"issue":"10","key":"6_CR108","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1161\/01.RES.0000268412.34364.50","volume":"100","author":"J Davis","year":"2007","unstructured":"Davis J, Wen H, Edwards T, Metzger JM (2007) Thin filament disinhibition by restrictive cardiomyopathy mutant R193H troponin I induces Ca2+-independent mechanical tone and acute myocyte remodeling. Circ Res 100(10):1494\u20131502","journal-title":"Circ Res"},{"issue":"5","key":"6_CR109","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jmb.2009.07.080","volume":"392","author":"Y Wen","year":"2009","unstructured":"Wen Y, Xu Y, Wang Y, Pinto JR, Potter JD, Kerrick WG (2009) Functional effects of a restrictive-cardiomyopathy-linked cardiac troponin I mutation (R145W) in transgenic mice. J Mol Biol 392(5):1158\u20131167","journal-title":"J Mol Biol"},{"issue":"7","key":"6_CR110","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1172\/JCI3880","volume":"102","author":"Q Yang","year":"1998","unstructured":"Yang Q, Sanbe A, Osinska H, Hewett TE, Klevitsky R, Robbins J (1998) A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy. J Clin Investig 102(7):1292\u20131300","journal-title":"J Clin Investig"},{"issue":"1\u20132","key":"6_CR111","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1023\/B:MCBI.0000041849.60591.45","volume":"263","author":"BM Palmer","year":"2004","unstructured":"Palmer BM, McConnell BK, Li GH, Seidman CE, Seidman JG, Irving TC, Alpert NR, Maughan DW (2004) Reduced cross-bridge dependent stiffness of skinned myocardium from mice lacking cardiac myosin binding protein-C. Mol Cell Biochem 263(1\u20132):73\u201380","journal-title":"Mol Cell Biochem"},{"key":"6_CR112","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3389\/fphys.2018.01442","volume":"9","author":"E Farrell","year":"2018","unstructured":"Farrell E, Armstrong AE, Grimes AC, Naya FJ, de Lange WJ, Ralphe JC (2018) Transcriptome analysis of cardiac hypertrophic growth in MYBPC3-null mice suggests early responders in hypertrophic remodeling. Front Physiol 9:1442","journal-title":"Front Physiol"},{"issue":"9","key":"6_CR113","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1093\/hmg\/dds022","volume":"21","author":"E Purevjav","year":"2012","unstructured":"Purevjav E, Arimura T, Augustin S, Huby AC, Takagi K, Nunoda S, Kearney DL, Taylor MD, Terasaki F, Bos JM, Ommen SR, Shibata H, Takahashi M, Itoh-Satoh M, McKenna WJ, Murphy RT, Labeit S, Yamanaka Y, Machida N, Park JE, Alexander PM, Weintraub RG, Kitaura Y, Ackerman MJ, Kimura A, Towbin JA (2012) Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations. Hum Mol Genet 21(9):2039\u20132053","journal-title":"Hum Mol Genet"},{"issue":"12","key":"6_CR114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050436","volume":"7","author":"Y Song","year":"2012","unstructured":"Song Y, Xu J, Li Y, Jia C, Ma X, Zhang L, Xie X, Zhang Y, Gao X, Zhang Y, Zhu D (2012) Cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1\/2 and TGF-beta signaling pathways. PLoS One 7(12):e50436","journal-title":"PLoS One"},{"issue":"6","key":"6_CR115","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1074\/jbc.M112.427484","volume":"288","author":"AM Manso","year":"2013","unstructured":"Manso AM, Li R, Monkley SJ, Cruz NM, Ong S, Lao DH, Koshman YE, Gu Y, Peterson KL, Chen J, Abel ED, Samarel AM, Critchley DR, Ross RS (2013) Talin1 has unique expression versus Talin 2 in the heart and modifies the hypertrophic response to pressure overload. J\u00a0Biol Chem 288(6):4252\u20134264","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"6_CR116","doi-asserted-by":"publisher","first-page":"e000899","DOI":"10.1161\/JAHA.114.000899","volume":"3","author":"M Ramratnam","year":"2014","unstructured":"Ramratnam M, Sharma RK, D\u2019Auria S, Lee SJ, Wang D, Huang XY, Ahmad F (2014) Transgenic knockdown of cardiac sodium\/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice. J Am Heart Assoc 3(4):e000899. https:\/\/doi.org\/10.1161\/JAHA.114.000899","journal-title":"J Am Heart Assoc"}],"container-title":["Advances in Experimental Medicine and Biology","Genome Editing in Cardiovascular and Metabolic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-19-5642-3_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:51:13Z","timestamp":1669920673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-19-5642-3_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"ISBN":["9789811956416","9789811956423"],"references-count":116,"URL":"https:\/\/doi.org\/10.1007\/978-981-19-5642-3_6","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2022,12,2]]},"assertion":[{"value":"2 December 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"None reported.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}